Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to Atherogenesis

Macrophages are core cellular elements of both early and advanced atherosclerosis. They take up modified lipoproteins and become lipid-loaded foam cells and secrete factors that influence other cell types in the artery wall involved in atherogenesis. Apoproteins E, AI, and SAA are all found on HDL w...

Full description

Bibliographic Details
Main Authors: Godfrey S. Getz, Catherine A. Reardon
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Pharmacology
Subjects:
SAA
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00536/full
id doaj-66a545c911c14e599ef36a63931452e1
record_format Article
spelling doaj-66a545c911c14e599ef36a63931452e12020-11-25T00:48:27ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-05-011010.3389/fphar.2019.00536453283Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to AtherogenesisGodfrey S. Getz0Catherine A. Reardon1Department of Pathology, The University of Chicago, Chicago, IL, United StatesBen May Department for Cancer Research, The University of Chicago, Chicago, IL, United StatesMacrophages are core cellular elements of both early and advanced atherosclerosis. They take up modified lipoproteins and become lipid-loaded foam cells and secrete factors that influence other cell types in the artery wall involved in atherogenesis. Apoproteins E, AI, and SAA are all found on HDL which can enter the artery wall. In addition, apoE is synthesized by macrophages. These three apoproteins can promote cholesterol efflux from lipid-loaded macrophages and have other functions that modulate macrophage biology. Mimetic peptides based on the sequence or structure of these apoproteins replicate some of these properties and are potential therapeutic agents for the treatment of atherosclerosis to reduce cardiovascular diseases.https://www.frontiersin.org/article/10.3389/fphar.2019.00536/fullmacrophageapoEapoA-ISAAcholesterol effluxoxidation
collection DOAJ
language English
format Article
sources DOAJ
author Godfrey S. Getz
Catherine A. Reardon
spellingShingle Godfrey S. Getz
Catherine A. Reardon
Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to Atherogenesis
Frontiers in Pharmacology
macrophage
apoE
apoA-I
SAA
cholesterol efflux
oxidation
author_facet Godfrey S. Getz
Catherine A. Reardon
author_sort Godfrey S. Getz
title Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to Atherogenesis
title_short Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to Atherogenesis
title_full Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to Atherogenesis
title_fullStr Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to Atherogenesis
title_full_unstemmed Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to Atherogenesis
title_sort apoproteins e, a-i, and saa in macrophage pathobiology related to atherogenesis
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2019-05-01
description Macrophages are core cellular elements of both early and advanced atherosclerosis. They take up modified lipoproteins and become lipid-loaded foam cells and secrete factors that influence other cell types in the artery wall involved in atherogenesis. Apoproteins E, AI, and SAA are all found on HDL which can enter the artery wall. In addition, apoE is synthesized by macrophages. These three apoproteins can promote cholesterol efflux from lipid-loaded macrophages and have other functions that modulate macrophage biology. Mimetic peptides based on the sequence or structure of these apoproteins replicate some of these properties and are potential therapeutic agents for the treatment of atherosclerosis to reduce cardiovascular diseases.
topic macrophage
apoE
apoA-I
SAA
cholesterol efflux
oxidation
url https://www.frontiersin.org/article/10.3389/fphar.2019.00536/full
work_keys_str_mv AT godfreysgetz apoproteinseaiandsaainmacrophagepathobiologyrelatedtoatherogenesis
AT catherineareardon apoproteinseaiandsaainmacrophagepathobiologyrelatedtoatherogenesis
_version_ 1725256015916564480